These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 327148)

  • 1. [Concentration of C-peptide in correlation to kidney function (author's transl)].
    Zilker T; Wiesinger H; Ermler R; Schweigart U; Bottermann P
    Klin Wochenschr; 1977 May; 55(10):471-4. PubMed ID: 327148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C-peptide in renal failure patients following stimulation of pancreatic secretion.
    Ramirez G; O'Neill WM; Bloomer HA; Jubiz W
    Clin Nephrol; 1979 Jun; 11(6):297-301. PubMed ID: 477046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma insulin, C-peptide and pancreatic glucagon responses to oral glucose load in chronic liver diseases (author's transl)].
    Okumura N; Hayakawa T; Noda A; Kondo T; Sakakibara A; Katada N; Kato K; Takeici M
    Nihon Shokakibyo Gakkai Zasshi; 1982 Jan; 79(1):38-45. PubMed ID: 7047806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration of C-peptide and insulin in serum of patients with acute virus hepatitis (author's transl)].
    Bottermann P; Zilker T; Ermler R; Paterek K; von Stransky B
    Klin Wochenschr; 1978 Oct; 56(20):1029-32. PubMed ID: 364178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
    Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma C-peptide in uraemic patients.
    Regeur L; Faber OK; Binder C
    Scand J Clin Lab Invest; 1978 Dec; 38(8):771-5. PubMed ID: 741207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous determination of blood insulin and plasma C-peptide levels. Value during assessment of glucose tolerance, especially in obese subjects (author's transl)].
    Pinget M; Demangeat C; Comte F; Brogard JM; Jacques C; Sapin R; Dorner M
    Ann Endocrinol (Paris); 1980; 41(5):399-414. PubMed ID: 7015991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical value of C-peptide assay (author's transl)].
    Vialettes B; Vague P
    Diabete Metab; 1980 Sep; 6(3):225-9. PubMed ID: 7002655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fructose diet and renal failure on the function of pancreatic islets.
    Pokrywczynska M; Flisinski M; Jundzill A; Krzyzanowska S; Brymora A; Deptula A; Bodnar M; Kloskowski T; Stefanska A; Marszalek A; Manitius J; Drewa T
    Pancreas; 2014 Jul; 43(5):801-8. PubMed ID: 24739489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta cell activity in uremia. Determination of plasma insulin and C peptide after intravenous administration of glucose].
    Panzetta G; Mioni G; Cristinelli L; Broccoli R; Maiorca R; Valentini U; Rigosa C; Giustina G
    Minerva Nefrol; 1979; 26(3):339-42. PubMed ID: 400448
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormalities of glucose metabolism in patients with early renal failure.
    Sechi LA; Catena C; Zingaro L; Melis A; De Marchi S
    Diabetes; 2002 Apr; 51(4):1226-32. PubMed ID: 11916949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin.
    Jaspan JB; Mako ME; Kuzuya H; Blix PM; Horwitz DL; Rubenstein AH
    J Clin Endocrinol Metab; 1977 Sep; 45(3):441-6. PubMed ID: 903396
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
    Unuigbe EI; Famodu AA; Umunna CE
    Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the radioimmunoassay kit for human C-peptide using the polyethylene glycol method (author's transl)].
    Yoshida T; Araki Y; Nakamura Y; Koyama K; Nakamura N
    Horumon To Rinsho; 1980 Nov; 28(11):1349-52. PubMed ID: 7449171
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E; Lüke F; Heidland A
    Med Klin; 1976 Nov; 71(45):1945-51. PubMed ID: 995035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.